Technological diversification, coherence and performance of firms.

Technological diversification at the level of the firm, i.e. the expansion of a firm’s technology base into a wide range of technology fields, is found to be a prevailing phenomenon in all three major industrialized regions: US, Europe and Japan, prompting the term multi-technology corporation. Whereas previous studies have provided insights into the composition of technology portfolios of multi-technology firms, little is known about the link between technological diversification and firms’ technological performance. Against a backdrop of the technology and innovation management literature, this article investigates the relationship between technological diversification and technological performance, taking into account the moderating role of technological coherence in firms’ technology portfolios. Hereby, technological coherence is defined as the degree to which technologies in a technology portfolio are technologically related. In order to measure the technological coherence of portfolios, a measure of technological relatedness of technology fields is constructed based on patent citation patterns found in 450,000 EPO patent grants. Two hypotheses are presented in this article: (1) Technological diversification has an inverted U-shaped relationship with technological performance; and (2) Technological coherence moderates the relationship between technological diversification and technological performance positively. These hypotheses are tested empirically using a panel dataset (1995-2003) on patent portfolios pertaining to 184 US, European, and Japanese firms. The firms selected are the largest R&D actors in five industries: Pharmaceuticals & Biotechnology, Chemicals, Engineering & General Machinery, IT Hardware (computers and communication equipment), and Electronics & Electrical Machinery. Empirical results, obtained by fixed-effects negative binomial regressions, support both hypotheses in this article. Technological diversification has an inverted U-shaped relationship with technological performance. While technological diversification offers opportunities for cross-fertilization and technology fusion, high levels of diversification may yield few marginal benefits as firms risk lacking sufficient levels of scale to benefit from wide-ranging technological capabilities, and firms may encounter high levels of coordination and integration costs. Further, the results show that the net benefits of technological diversification are higher in technologically coherent technology portfolios. If firms build up a technologically coherent diversified portfolio, the presence of sufficient levels of scale is ensured and coordination costs are limited. This article clearly identifies the important role of technological coherence and points out in the discussion session the relevance of future research on interface management practices directed to the realization of the benefits of technological diversification.technology diversification; technology relatedness; innovation; firm performance;

Developing technology in the vicinity of science: Do firms really benefit? An empirical assessment on the level of Italian provinces.

The article examines whether firms benefit from the presence of universities when developing technology. By estimating regional knowledge production functions for 101 Italian regions, we observe a strong positive relation between industrial technological performance – measured by patents – and the local presence of universities. In addition, 'academic' regions witness higher levels of industrial technological output, the more pronounced the scientific eminence of the regional universities. Finally, our analysis indicates that the observed spillover effects are field-specific, with domains situated in the vicinity of science benefiting most. Together, these findings suggest complementary roles for scientific and industrial actors within regional innovation systems.Regional Innovation Systems; Technology transfer; University-Firm Knowledge Spillovers; Technology; Science; Firms; Research;

Internal basic research, external basic research and the technological performance of pharmaceutical firms.

We evaluate the impact of basic research on pharmaceutical firms’ technological performance, distinguishing between internal basic research and the exploitation of external basic research findings. We find that firms increase their performance by engaging more in internal basic research, in particular if basic research is conducted in collaboration with university scientists. The exploitation of external basic research improves performance, while the magnitude increases with firms’ involvement in internal basic research. Hence, internal basic research and the exploitation of external basic research are complements, suggesting that internal basic research provides firms with the skills to exploit external basic research more effectively.basic research; industrial innovation; pharmaceutical industry;

The market value of blocking patent citations

There is a growing literature that aims at assessing the private value of knowledge assets and patents. It has been shown that patents and their quality as measured by citations received by future patents contribute significantly to the market value of firms beyond their R&D stocks. This paper goes one step further and distinguishes between different types of forward citations patents can receive at the European Patent Office. While a patent can be cited as non-infringing state of the art, it can also be cited because it threatens the novelty of patent applications ('blocking citations'). Empirical results from a market value model for a sample of large, R&D-intensive U.S., European and Japanese firms show that patents frequently cited as blocking references have a higher economic value for their owners than patents cited for nonblocking reasons. This finding adds to the patent value literature by showing that different types of patent citations carry different information on the economic value of patents. The result further suggests that the total number of forward citations can be an imprecise measure of patent value. --Market Value,Patents,Citations,Patent Value

Does Excellence in Academic Research Attract Foreign R&D?.

We examine the role of host countries’ academic research strengths in global R&D location decisions by multinational firms. While we expect that a firm’s propensity to perform R&D in a host country increases with the strength of local academic research, firms are expected to be heterogeneously positioned to benefit from academic research strengths due to differences in the capacity to absorb and utilize scientific knowledge. We find support for these conjectures in an analysis of foreign R&D activities in 40 host countries and 30 technology fields by 176 leading European, US and Japanese firms during the periods 1995-1998 and 1999-2002. Controlling for a wide range of host country factors, the number of relevant ISI publications by scientists based in the host country has a substantial positive impact on the propensity to conduct foreign R&D. The effect of academic research is significantly larger for firms with a stronger science orientation in R&D - as indicated by citations to scientific literature in prior patents. For host countries with a strong relevant science base, this greater responsiveness of science oriented firms more than offsets a generally greater inclination to concentrate R&D at home. The findings appear robust across a variety of specifications.

Do Firms Benefit from Being Present in Multiple Technology Clusters? An Assessment of the Technological Performance of Biopharmaceutical Firms

Firms active in knowledge-intensive fields are increasingly organizing their R&D activities on an international scale. This paper investigates whether firms active in biotechnology can improve their technological performance by developing R&D activities in multiple technology clusters. Regions in the US, Japan and Europe, that host a concentration of biotechnology activity are identified as clusters. Fixed-effect panel data analyses with 59 biopharmaceutical firms (period 1995-2002) provides evidence for a positive, albeit diminishing (inverted-U shape) relationship between the number of technology clusters in which a firm is present and its overall technological performance. This effect is distinct from a mere multi-location effect.region, clusters, biotechnology, technology clusters

Technological activities and their impact on the financial performance of the firm: Exploitation and exploration within and between firms

This paper analyzes the consequences for financial performance of technology strategies categorized along two dimensions: (1) explorative versus exploitative and (2) solitary versus collaborative. The financial performance implications of firms’ positioning along these two dimensions has important managerial implications, but has received only limited attention in prior studies. Drawing on organizational learning theory and technology alliances literature, a set of hypotheses on the performance implications of firms’ technology strategies are derived. These hypotheses are tested empirically on a panel dataset (1996-2003) of 168 R&D-intensive firms based in Japan, the US and Europe and situated in five different industries (chemicals, pharmaceuticals, ICT, electronics, non-electrical machinery). Patent data are used to construct indicators of explorative versus exploitative technological activities (activities in new or existing technology domains) and collaborative versus solitary technological activities (joint versus single patent ownership). The financial performance of firms is measured via a market value indicator: Tobin’s Q index.Innovation, Tobin’s q, R&D collaboration, exploration & exploitation

Do firms benefit from being present in technology clusters? Evidence from a panel of biopharmaceutical firms.

This paper investigates whether firms active in biotechnology can improve their technological performance by developing R&D activities in technology clusters. Regions that host a concentration of biotechnology activity are identified as technology clusters (level of US states, Japanese prefectures and European NUTS2 regions). A fixed effect panel data analysis on a set of 59 biopharmaceutical firms (period 1995-2002) provides evidence for a positive, albeit diminishing (inverted-U shape) relationship between the number of technology clusters in which a firm is present and its total technological performance. This effect is distinct from a mere multi-location effect.Cluster; Innovation; Biotechnology;

The market value of blocking patent citations.

There is a growing literature that aims at assessing the private value of knowledge assets and patents. It has been shown that patents and their quality as measured by citations received by future patents contribute significantly to the market value of firms beyond their R&D stocks. This paper goes one step further and distinguishes between different types of forward citations patents can receive at the European Patent Office. While a patent can be cited as non-infringing state of the art, it can also be cited because it threatens the novelty of patent applications (“blocking citations”). Empirical results from a market value model for a sample of large, R&D-intensive U.S., European and Japanese firms show that patents frequently cited as blocking references have a higher economic value for their owners than patents cited for nonblocking reasons. This finding adds to the patent value literature by showing that different types of patent citations carry different information on the economic value of patents. The result further suggests that the total number of forward citations can be an imprecise measure of patent value.market value; patents; citations; patent value;

Does Excellence in Academic Research Attract Foreign R&D?

We examine the role of host countries’ academic research strengths in global R&D location decisions by multinational firms. While we expect that a firm’s propensity to perform R&D in a host country increases with the strength of local academic research, firms are expected to be heterogeneously positioned to benefit from academic research strengths due to differences in the capacity to absorb and utilize scientific knowledge. We find support for these conjectures in an analysis of foreign R&D activities in 40 host countries and 30 technology fields by 176 leading European, US and Japanese firms during the periods 1995-1998 and 1999-2002. Controlling for a wide range of host country factors, the number of relevant ISI publications by scientists based in the host country has a substantial positive impact on the propensity to conduct foreign R&D. The effect of academic research is significantly larger for firms with a stronger science orientation in R&D - as indicated by citations to scientific literature in prior patents. For host countries with a strong relevant science base, this greater responsiveness of science oriented firms more than offsets a generally greater inclination to concentrate R&D at home. The findings appear robust across a variety of specifications.R&D Internationalization, Knowledge sourcing, Absorptive capacity, Industry-science links